Clinical documentation: which AI startup is ahead?

Which clinical documentation AI startups are really in the race?

The clinical documentation AI market currently has nine serious independent startups, although only six have enough scale or product depth to compete for broad leadership.

We include Abridge, Ambience Healthcare, Suki, Nabla, Heidi Health, Tandem Health, DeepScribe, Freed, and TORTUS. All nine have moved beyond an early demo and can point to clinicians, healthcare organizations, or health systems regularly using their products.

The companies fall into three groups. Abridge, Ambience, Suki, and Nabla mainly sell to large US healthcare organizations. Heidi and Freed grew by making it easy for individual clinicians and smaller practices to start without waiting for a hospital procurement process. DeepScribe, Tandem, and TORTUS have built stronger positions around complex specialties, European healthcare systems, or the NHS.

Microsoft’s Nuance, Epic, and Oracle remain important competitors, but we exclude them from the startup ranking because they are established healthcare technology companies. We also exclude Augmedix because Commure acquired it.

Funding totals are approximate. Private startups sometimes report extensions, strategic investments, and secondary transactions differently, so the amounts below should be treated as useful ranges rather than audited totals.

Startup	Main position	Approximate funding raised	Strongest current advantage
Abridge	Enterprise clinical intelligence platform	≈$800M	Largest major health-system footprint
Ambience Healthcare	Documentation, coding, and revenue integrity	≈$343M	Complex specialties and inpatient workflows
Suki	Clinical assistant distributed through EHRs	≈$168M	EHR partnerships and measured ROI
Nabla	Documentation, dictation, coding, and commands	$120M	Broad institutional adoption and strong research
Heidi Health	Global product-led clinical assistant	Nearly $100M	International clinician adoption
DeepScribe	Specialty-focused ambient documentation	≈$60M	Oncology and other complex specialties
Tandem Health	Regulated European clinical assistant	≈$59.5M	European integrations and regulation
Freed	AI assistant for independent clinicians	$34M	Low-friction adoption and accessible pricing
TORTUS	NHS-focused regulated assistant	≈$8.5M	UK healthcare positioning

Is Abridge already the clear leader in clinical documentation AI?

Abridge is currently the clear overall leader in clinical documentation AI. Ambience is the only startup close enough to challenge it across the full enterprise market.

Abridge says its platform is live in more than 300 health systems and supports over 100 million clinical conversations each year. Those deployments cover outpatient visits, emergency departments, inpatient care, and nursing. No other independent startup has disclosed the same combination of institutional scale and workflow breadth.

The customer portfolio also carries unusual weight. Abridge has been selected by systems including Kaiser Permanente, UPMC, Mayo Clinic, Johns Hopkins Medicine, Duke Health, Yale New Haven Health, Northwestern Medicine, and Geisinger. Winning one prestigious hospital may reflect local preferences. Repeating that success across hundreds of organizations points to a product that can survive security reviews, clinical governance, integrations, training, and large-scale rollout.

Ambience has disclosed fewer health-system relationships, although some of its wins are especially revealing. MultiCare asked more than 550 clinicians across over 20 specialties to compare three leading ambient AI vendors. Ambience won the evaluation and secured a broader enterprise deployment. Abridge clearly does not win every serious head-to-head test.

Ambience is also pursuing more complicated clinical and financial workflows. Its platform covers outpatient and inpatient documentation, coding, clinical documentation integrity, chart review, revenue protection, and care coordination. Deployments at Houston Methodist, Cleveland Clinic, MultiCare, Ardent Health, and John Muir Health support the argument that Ambience performs well in complex environments.

Suki and Nabla form the next group. Nabla now reports adoption across roughly 190 healthcare systems. Suki has built deep relationships with EHR companies and published some of the market’s clearest customer outcome data. Both are mature enterprise products, but neither currently matches Abridge’s combined scale, breadth, and customer portfolio.

Heidi leads through a different route. Its product spreads quickly among individual clinicians and smaller organizations, giving it enormous global activity. That reach has not yet produced enough evidence that Heidi can consistently replace Abridge or Ambience inside the largest US health systems.

The market structure is quite sharp today. Abridge leads the overall category. Ambience is the strongest direct challenger. Suki and Nabla sit close behind, while Heidi, Tandem, DeepScribe, Freed, and TORTUS lead narrower parts of the market.

If you want more recent data on this point, please see our latest healthcare AI market report.

Who has the largest real-world clinical documentation footprint?

Abridge has the largest proven enterprise footprint in clinical documentation AI, while Heidi has reached a similar level of raw weekly activity through a much broader mix of clinicians and organizations.

Vendor scale figures require careful reading. A health system can include many hospitals and thousands of clinicians. A care organization may be a small clinic. Registered users may rarely open the software, while completed consultations show actual activity.

Abridge reports more than 300 live health systems and over 100 million annual conversations. That equals roughly 1.9 million conversations a week. The institutional nature of those deployments makes the figure particularly strong: large health systems generally require long purchasing, security, integration, and governance processes before going live.

Heidi reports more than two million clinical sessions each week. Its raw usage therefore sits in the same order of magnitude as Abridge’s annualized conversation volume. The commercial meaning is different because Heidi’s activity comes from many countries, smaller practices, individual users, and free or self-serve accounts.

Nabla’s current materials list around 190 healthcare systems, up from more than 130 when the company announced its Series C. Tandem says it serves over 5,000 European care organizations and connects to more than 100 medical-record systems. DeepScribe reports more than 2,800 clinics and health systems, with over eight million visits captured.

Those larger organization counts do not place Tandem or DeepScribe ahead of Abridge. Their customer definitions include many smaller clinics and practices. Abridge’s count is concentrated among larger and more operationally demanding systems.

Suki provides one of the cleanest channel-level figures. Through athenahealth alone, more than 450 practices and 3,400 monthly active users generate around 500,000 notes each month. Freed reports more than 26,000 clinicians, giving it the largest disclosed base among US products primarily aimed at independent practitioners.

Startup	Best disclosed scale metric	Approximate weekly activity	How we read it
Abridge	300+ live health systems	≈1.9M conversations	Strongest large-enterprise evidence
Heidi	2M+ clinical sessions weekly	2M+ sessions	Largest global product-led usage
Nabla	≈190 healthcare systems	Not disclosed	Closest disclosed institutional count
Tandem	5,000+ European care organizations	Not disclosed	Broad European distribution
DeepScribe	2,800+ clinics and health systems	Not disclosed	Large specialty-focused footprint
Suki	450+ athenahealth practices	≈125,000 notes	Strong embedded EHR channel
Freed	26,000+ clinicians	Not disclosed	Large independent-clinician base
TORTUS	2.5M cumulative consultations	Not disclosed	Meaningful NHS-centered usage

Which clinical documentation startup is growing fastest now?

Abridge is currently growing fastest in the market’s hardest segment: large health systems.

Abridge passed 100 enterprise deployments in early 2025, reported more than 150 systems several months later, moved beyond 200 before the end of that year, and has now exceeded 300. The company roughly tripled its institutional footprint in around 16 months.

That growth carries more weight than a normal software user curve. Each new health-system deployment may involve negotiations with legal, security, IT, compliance, clinical leadership, and dozens of specialties. Abridge expanded rapidly while also moving into inpatient documentation, nursing, coding, evidence retrieval, and payer workflows.

Nabla has also accelerated. Its disclosed health-system count increased from more than 130 to around 190, representing growth of roughly 46%. Recent rollouts at University of Iowa Health Care, M Health Fairview, LCMC Health, and UC San Diego Health suggest that Nabla is becoming a standard enterprise option rather than remaining a limited pilot product.

Suki has published the cleanest short-term adoption rate within a specific EHR channel. Usage across athenahealth increased 50% over six months, reaching 3,400 monthly active clinicians and around half a million monthly notes. That level of repeat usage is more meaningful than a count of users who signed up once.

Heidi may still be attracting individual clinicians faster than any competitor, but its recent public figures do not provide a consistent starting point for calculating the current growth rate. Two million weekly sessions prove large-scale demand. They do not provide the same clean year-over-year comparison.

Abridge is therefore the strongest measurable growth leader, with Nabla and Suki gaining quickly behind it. Heidi remains the wild card because its bottom-up distribution can expand much faster than a traditional enterprise sales organization.

If you want more recent data on this point, please see our latest healthcare AI market report.

Which clinical documentation AI product is mature enough for complicated care?

Abridge currently has the most mature clinical documentation platform overall. Ambience looks strongest when inpatient complexity, coding, and revenue integrity dominate the buying decision.

Abridge now supports work before, during, and after a patient encounter. The platform can prepare pre-visit summaries, draft documentation from the conversation, connect note content to its source, suggest codes, prepare orders for review, and create patient-facing summaries. It operates across outpatient, emergency, inpatient, and nursing settings.

The company has also proved that it can deploy these workflows across very large organizations. UPMC is expanding Abridge to more than 12,000 clinicians. Geisinger reached more than 1,000 clinicians within ten months. WVU Medicine has extended the platform across a multistate network of hospitals and clinics. Those rollouts show that Abridge can handle the operational work that follows a successful pilot.

Ambience has developed greater depth around the medical chart and the financial consequences of documentation. Its system can review previous notes, diagnoses, imaging, medications, laboratory results, pathology, and problem lists. It then uses that context to support documentation, coding, clinical documentation integrity, and revenue-cycle work.

Houston Methodist provides a strong example. The health system reported an 80% utilization rate and a 40% reduction in documentation time before expanding Ambience across ambulatory, emergency, and inpatient settings. High utilization across a broad group of clinicians suggests the product remains useful after the novelty of a pilot wears off.

Ambience also integrates with Epic, Oracle Cerner, athenahealth, and other major EHRs. Its work with Epic’s Ambient Module and FHIR APIs allows documentation and coding information to move directly into the clinical record.

Suki has built the most efficient EHR distribution strategy. Its technology powers athenahealth’s native Ambient Notes, and athenahealth has named Suki its preferred ambient AI partner. Some practices can reportedly go live within about five business days. Suki also works with MEDITECH, Epic, Oracle Health, MEDENT, Azalea Health, and other record systems.

Nabla combines ambient documentation with dictation, coding, and voice commands. University of Iowa Health Care made Nabla available across the organization, while M Health Fairview selected the company’s combined ambient and dictation product. That broader product gives Nabla a chance to replace several older tools rather than adding one more application.

DeepScribe remains especially credible in oncology, cardiology, urology, gastroenterology, and other specialties with long histories and complicated treatment plans. The company says healthcare organizations using DeepScribe account for roughly three million cancer-care visits annually.

Tandem has built a different form of maturity in Europe. Its scribe and coding assistant have received EU MDR Class IIa certification, and its regulated clinical decision-support product is now being introduced with selected customers.

For a health system seeking one broad and proven platform, Abridge remains the strongest choice. Ambience may be more attractive when detailed chart context, inpatient documentation, and coding accuracy matter most.

Which AI scribe produces the best clinical notes?

Abridge currently has the strongest overall quality case, although public evidence still cannot prove that one AI scribe produces the best notes across every specialty.

Abridge won the Best in KLAS award for ambient AI in revenue-cycle management for a second consecutive year. KLAS bases its results on interviews with customers rather than a test designed by the vendor, which gives the ranking more credibility than a company accuracy claim.

The wider evidence also supports real clinical value. A study published in JAMA Network Open followed 263 clinicians across six health systems using Abridge. After 30 days, the share reporting burnout fell from 51.9% to 38.8%. Clinicians also reported less cognitive load, lower after-hours documentation, and greater attention to patients.

The study relied on self-reported outcomes and voluntary participants, so it tells us more about usefulness than exact note accuracy. Still, the size and multicenter design make it one of the stronger pieces of evidence produced by an independent ambient AI company.

Nabla has participated in the category’s strongest randomized comparison. Physicians were assigned to Nabla, Microsoft DAX, or a control group. The study found efficiency gains from ambient documentation but did not establish a universal quality winner. Nabla deserves credit for allowing its product to be examined directly against a major incumbent.

Ambience received a 97.7 score in a KLAS Spotlight report, while DeepScribe has advertised a KLAS score above 99. Both scores are impressive. Their earlier KLAS samples included only 14 organizations for Ambience and seven for DeepScribe, however, making them less conclusive than results drawn from a broader customer base.

Research covering the wider ambient AI category gives a more cautious picture. A controlled simulation across cardiology, gastroenterology, hematology-oncology, and neurology found meaningful differences between specialties. Notes tended to perform better on succinctness than thoroughness, and no single system showed perfect performance across every clinical context.

A larger JAMA study followed 8,581 clinicians across five academic centers. AI-scribe adoption reduced total EHR time by about 13 minutes and documentation time by roughly 16 minutes per week, while adding around half a patient visit. After-hours EHR use did not improve significantly.

Ambient documentation creates real benefits, but typical gains may be smaller than the largest company case studies imply.

Startup	Strongest public quality evidence	Main limitation
Abridge	Two consecutive Best in KLAS awards and a six-system study	More evidence on clinician burden than exact note accuracy
Nabla	Randomized comparison against Microsoft DAX and a control group	Smaller installed base than Abridge
Ambience	97.7 KLAS Spotlight score and strong competitive evaluations	Limited KLAS sample
Suki	KLAS-validated outcomes across several health systems	More evidence on ROI than clinical accuracy
DeepScribe	Very high KLAS scores and specialty customers	Small samples and many company-reported figures
Heidi	Large usage base and several detailed case studies	Most outcome evidence comes from Heidi customers

Which clinical documentation startup gives customers the best economics?

Ambience currently offers the strongest financial case for large health systems, while Suki has published the broadest independently reviewed ROI evidence.

At St. Luke’s, Ambience reported approximately $13,000 in additional annual revenue per clinician through better documentation and coding. The American Academy of Professional Coders and KLAS reviewed the figure, making it one of the more credible financial claims in the category.

Ambience can create value through more accurate E/M levels, supported diagnosis capture, fewer coding queries, and stronger documentation during audits. These gains are easier for a health system to place in a budget than a general promise of reduced clinician frustration.

Suki’s evidence covers a wider range of outcomes. A KLAS review examined deployments at three health systems and looked at documentation time, adoption, patient experience, coding, and operational performance. At McLeod Health, 81% of 249 eligible providers adopted Suki and produced more than 150,000 notes.

Heidi and Freed offer a simpler economic proposition for individual clinicians. Both allow users to start with little implementation work, and Heidi provides a free core product. A Heidi customer, Advanced Urology, calculated a return of more than ten times its setup costs after 37 users completed 13,700 consultations over 16 weeks. The case study came from Heidi, but the activity and time calculations were unusually detailed.

Enterprise pricing remains too opaque for a precise value-for-money ranking. Based on disclosed outcomes, Ambience has the strongest large-system revenue case, Suki has the most rounded external validation, and Heidi or Freed offer the lowest-risk entry point for smaller practices.

If you want more recent data on this point, please see our latest healthcare AI market report.

Who leads clinical documentation AI outside the United States?

Heidi currently leads international clinical documentation adoption, while Tandem has built the strongest regulated European enterprise platform.

Heidi reports more than two million weekly clinical sessions and support for over 110 languages. The company says its product is used by around half of UK general practitioners, across 15 NHS trusts, and during more than 1.5 million NHS appointments each month.

Its reach extends across the UK, Australia, Canada, the United States, and many smaller markets where the largest US enterprise vendors have limited visibility. Heidi has also expanded beyond documentation through evidence search, referrals, patient communications, coding, and remote workflows.

Tandem has taken a more institutional route. It serves more than 5,000 European care organizations, integrates with over 100 record systems, and has obtained EU MDR Class IIa status for both its scribe and coding assistant.

A four-year NHS agreement gives roughly 10,000 clinicians access to Tandem. The company has also expanded through partnerships and acquisitions in the Nordic countries, the UK, Germany, and the Netherlands.

TORTUS remains a credible UK specialist. It reports more than 2.5 million consultations, holds UKCA Class IIa certification, and has tested its product in NHS settings including general practice, emergency medicine, and mental healthcare.

Heidi leads international activity and bottom-up adoption. Tandem leads regulated European enterprise infrastructure. TORTUS holds a smaller but serious NHS position.

Who is moving beyond AI note-taking most convincingly?

Abridge has the strongest chance of turning clinical documentation into a broader healthcare platform because it already sits inside more large health systems than any startup competitor.

Abridge is expanding into pre-visit preparation, inpatient rounding, nursing, coding, orders, patient summaries, payer workflows, clinical evidence, and trial matching. The company is also working with NVIDIA on a foundation model designed specifically for clinical conversations.

That expansion benefits from Abridge’s installed base. New products can be introduced to organizations where the company has already passed security, procurement, governance, and integration reviews.

Ambience may currently have greater depth in coding and revenue integrity. Its platform can suggest ICD-10 and CPT codes, support E/M selection, identify documentation gaps, validate diagnoses, and review the wider chart. This gives Ambience a direct connection to hospital revenue rather than limiting the product to time savings.

Nabla combines ambient documentation, dictation, coding, and voice commands. Suki is moving into clinical reasoning, intake, follow-up, and revenue-cycle work. Heidi has added evidence search and several administrative workflows. Tandem now offers regulated coding and decision support. Even Freed has expanded into visit preparation, letters, codes, and front-desk tasks.

The market is converging on a broader clinical assistant. Abridge currently owns the strongest distribution base for that transition, with Ambience closest in product depth.

Can Epic, Microsoft, and Oracle crush the clinical documentation AI startups?

Epic, Microsoft, and Oracle will put heavy pressure on weaker AI scribes, but the leading startups already have enough specialization and customer depth to remain serious competitors.

Epic now offers native AI Charting inside its EHR. The product listens during encounters, drafts notes, supports voice personalization, and can suggest clinical actions. Hospitals using Epic can avoid an additional integration, vendor review, and contract.

Microsoft is expanding Dragon Copilot across physician documentation, nursing, mobile workflows, multilingual use, and broader clinical tasks. Nuance gives Microsoft an established healthcare customer base and decades of experience in medical speech technology.

Oracle’s Clinical AI Agent can draft documentation, support coding, schedule work, and prepare orders. Oracle says customers have already saved more than 200,000 documentation hours, while inpatient and emergency-department note generation are commercially available.

These products create a difficult environment for startups offering only a competent note. Many hospitals will accept a slightly weaker product when it comes bundled with the EHR, requires less implementation, and sits under an existing contract.

Abridge, Ambience, Suki, and Nabla have stronger defenses. They work across several EHRs, move faster, specialize more deeply, and allow health systems to avoid giving one incumbent control over every AI workflow.

Epic creates the largest direct risk for Abridge because many Abridge customers use Epic. Abridge can still win by proving that its wider clinical intelligence platform delivers substantially more value than native charting.

Ambience can defend itself through coding, inpatient documentation, and revenue integrity. Suki benefits from being both an independent assistant and a technology partner for EHR companies. Nabla can compete through its combined documentation, dictation, and command platform.

The established vendors will probably eliminate many mid-tier scribes. The leading startups have already moved far enough beyond basic notes to keep competing.

If you want more recent data on this point, please see our latest healthcare AI market report.

Which clinical documentation startup has the strongest momentum now?

Abridge has the strongest overall momentum, while Ambience and Tandem have gained the most ground relative to their earlier positions.

Abridge has recently expanded its institutional footprint, launched a much wider product platform, and deepened several large deployments. The company is moving into payer, life-sciences, and inpatient workflows while continuing to grow its core documentation business.

Ambience has assembled the strongest challenger run. It won MultiCare’s comparative process, expanded at Houston Methodist, introduced chart-aware inpatient tools, strengthened its coding products, and won the KLAS/CHIME Trailblazer Award. The strategy is clear: connect documentation directly to clinical and financial outcomes.

Nabla has become more dangerous through enterprise expansion, dictation, coding, and stronger health-system case studies. Suki continues to grow through EHR partnerships, including athenahealth and Sevocity.

Tandem has moved fastest in Europe. It secured access to 10,000 NHS clinicians, obtained EU MDR Class IIa certification for scribing and coding, expanded to more than 5,000 organizations, and introduced regulated clinical decision support.

Abridge remains the momentum leader because it is adding new capabilities while extending an already large installed base. Ambience is gaining ground quickly enough to make the top of the market genuinely competitive.

Which clinical documentation AI startups are actually ahead?

Abridge is ahead overall today, and the gap is wide enough to call it the clear market leader.

We give the greatest weight to live deployments, regular usage, product maturity, customer quality, independent evidence, rollout capacity, and expansion into valuable downstream workflows. Funding helps companies build these advantages, but it does not count as leadership by itself.

Abridge leads across most of the dimensions that decide large health-system purchases. It operates in hundreds of systems, supports a vast volume of clinical conversations, covers several care settings, has strong independent evidence, and is expanding into coding, nursing, orders, clinical evidence, payment, and payer workflows.

Ambience ranks second because it is winning demanding health systems and may already offer a stronger product for some inpatient, specialty, coding, and revenue-integrity workflows. Its remaining challenge is scale. Ambience has yet to show that it can reproduce its best deployments across an institutional base approaching Abridge’s size.

Suki narrowly takes third place. Its EHR distribution, high adoption, mature integrations, and externally reviewed ROI create a strong commercial position. Nabla sits very close behind, with broader disclosed health-system adoption and the category’s best randomized comparative study.

Heidi ranks fifth because its international usage is too large to overlook. Its product-led model reaches clinicians that enterprise-first companies often miss. More evidence is still needed that this reach can consistently turn into large, durable health-system contracts.

Tandem now deserves sixth place. Its regulatory progress, European EHR coverage, NHS access, and large care-organization base give it the strongest European enterprise position.

DeepScribe follows because of its strength in oncology and other complex specialties. Freed leads the low-friction independent-practice segment, while TORTUS remains a credible but geographically concentrated NHS specialist.

Three developments could change the ranking. Ambience could close the gap by converting recent customer wins into a much larger installed base. Heidi could rise quickly if its global clinician usage produces deep enterprise adoption. Epic, Microsoft, and Oracle could also reduce the value of basic note generation, pushing every startup toward more complicated clinical and financial workflows.

Abridge currently owns the strongest combination of scale, evidence, maturity, and distribution. Ambience is the closest challenger. Suki and Nabla form the next competitive pair, while Heidi and Tandem lead the two most important alternative routes into the market.

Rank	Startup	Why it currently holds this position
1	Abridge	Largest enterprise footprint, strongest overall evidence, broadest mature platform, and continued expansion into high-value workflows
2	Ambience Healthcare	Strongest direct challenger, with exceptional inpatient, specialty, coding, and revenue-integrity depth
3	Suki	Powerful EHR distribution, high adoption, mature integrations, and independently reviewed ROI
4	Nabla	Broad health-system reach, strong comparative research, and a credible documentation-plus-dictation platform
5	Heidi Health	Clear global product-led adoption leader with exceptional weekly usage
6	Tandem Health	Strongest regulated European enterprise platform and fastest-rising regional contender
7	DeepScribe	Leading specialty-focused product, particularly in oncology and complex ambulatory care
8	Freed	Strongest low-friction option for independent US clinicians and smaller practices
9	TORTUS	Proven and regulated NHS specialist with a narrower geographic position

If you want more recent data on this point, please see our latest healthcare AI market report.

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living "market pitch" documents for emerging markets: AI, synthetic biology, new proteins, and more. Instead of outdated PDFs or hallucinated LLM answers, our clients get a clean, visual, always-updated view of what's really happening: key players, deals, regulations, and signals that matter. Learn more about us.